JP2021520352A5 - - Google Patents

Info

Publication number
JP2021520352A5
JP2021520352A5 JP2020554077A JP2020554077A JP2021520352A5 JP 2021520352 A5 JP2021520352 A5 JP 2021520352A5 JP 2020554077 A JP2020554077 A JP 2020554077A JP 2020554077 A JP2020554077 A JP 2020554077A JP 2021520352 A5 JP2021520352 A5 JP 2021520352A5
Authority
JP
Japan
Prior art keywords
composition according
nanoparticles
biological polymer
composition
group
Prior art date
Application number
JP2020554077A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019195546A5 (https=
JP2021520352A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025782 external-priority patent/WO2019195546A1/en
Publication of JP2021520352A publication Critical patent/JP2021520352A/ja
Publication of JP2021520352A5 publication Critical patent/JP2021520352A5/ja
Publication of JPWO2019195546A5 publication Critical patent/JPWO2019195546A5/ja
Priority to JP2023124313A priority Critical patent/JP2023133446A/ja
Pending legal-status Critical Current

Links

JP2020554077A 2018-04-04 2019-04-04 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法 Pending JP2021520352A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023124313A JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652548P 2018-04-04 2018-04-04
US62/652,548 2018-04-04
PCT/US2019/025782 WO2019195546A1 (en) 2018-04-04 2019-04-04 Self-assembled gels for controlled delivery of biologics and methods of making thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023124313A Division JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Publications (3)

Publication Number Publication Date
JP2021520352A JP2021520352A (ja) 2021-08-19
JP2021520352A5 true JP2021520352A5 (https=) 2022-04-11
JPWO2019195546A5 JPWO2019195546A5 (https=) 2022-04-11

Family

ID=66248685

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554077A Pending JP2021520352A (ja) 2018-04-04 2019-04-04 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法
JP2023124313A Pending JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023124313A Pending JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Country Status (6)

Country Link
US (2) US20190307885A1 (https=)
EP (1) EP3773478A1 (https=)
JP (2) JP2021520352A (https=)
AU (2) AU2019247375B2 (https=)
CA (1) CA3096745A1 (https=)
WO (1) WO2019195546A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013540757A (ja) 2010-09-24 2013-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
CA3113948A1 (en) * 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
US20240024231A1 (en) * 2020-10-01 2024-01-25 Standard Millox Pharmaceuticals Oy Hydrogel material
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130097813A (ko) * 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
WO2010053140A1 (ja) * 2008-11-05 2010-05-14 国立大学法人 東京医科歯科大学 ヒアルロン酸誘導体、およびその医薬組成物
CA2767443A1 (en) * 2009-07-09 2011-01-13 Polymers Crc Limited Biopolymer hybrid gel-depot delivery system
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
JP2013540757A (ja) * 2010-09-24 2013-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
EP2968135A4 (en) * 2013-03-14 2016-10-26 Massachusetts Inst Technology INJECTABLE, MULTILAYER, SELF-COMPOSITE PEPTIDE RUBBER HYDROGELS FOR LONG-TERM AND DELAYED RELEASE OF HUMAN ANTIBODIES
WO2017186928A1 (en) 2016-04-29 2017-11-02 Curevac Ag Rna encoding an antibody
US20170319500A1 (en) * 2016-05-06 2017-11-09 The Brigham And Women's Hospital, Inc. Self-assembled gels for controlled delivery of biologics and labile agents
EP3482199A1 (en) 2016-07-08 2019-05-15 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
GB2552473A (en) 2016-07-21 2018-01-31 Evox Therapeutics Ltd Surface decoration of extracellular vesicles
SG11201900616UA (en) 2016-08-02 2019-02-27 Visterra Inc Engineered polypeptides and uses thereof
WO2018031954A1 (en) 2016-08-12 2018-02-15 Biogen Ma Inc. Identifying components of dry powder mixtures using raman spectroscopy
JP7500195B2 (ja) 2016-08-23 2024-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア タンパク質分解により切断可能なキメラポリペプチド及びそれらの使用方法

Similar Documents

Publication Publication Date Title
JP2021520352A5 (https=)
CN113041356B (zh) 血筒素靶向载药体系、制备方法及其应用
US20230364014A1 (en) Self-assembled gels for controlled delivery of biologics and methods of making thereof
CN103374128B (zh) 两亲性三嵌段共聚物、聚合物纳米载体制剂及制备方法
CN103251561B (zh) 一种双敏感可崩解式纳米囊泡药物载体制剂及其制备方法
CN101703480B (zh) 明胶-壳聚糖/蒙脱土载药微球及制备方法
CN105617362B (zh) 一种新型的胰岛素－磷脂－壳聚糖自组装微粒载体及其制剂
KR20170106460A (ko) 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
US20170319500A1 (en) Self-assembled gels for controlled delivery of biologics and labile agents
CN114796155B (zh) 天然活性物质-玉米蛋白纳米颗粒及其制备方法和用途
CN111450258B (zh) 一种促进蛋白药物跨黏液渗透的口服给药系统及其制备
CN104817660A (zh) 一种改性羧甲基壳聚糖纳米凝胶的制备
JP2019516689A5 (https=)
JPWO2019195546A5 (https=)
CN102641245B (zh) 一种装载难溶性药物的壳聚糖-壳聚糖衍生物纳米球、制备方法及其作为口服制剂的应用
CN111904945A (zh) 一种纳米混悬液的口服给药体系和构建方法及其应用
CN104490847B (zh) 一种热变性制备稳定白蛋白纳米颗粒的方法
JP2022103299A (ja) 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
CN103239729A (zh) 含超支化聚合物与磷脂的纳米载体及其制备方法和应用
CN110214145B (zh) CP-iRGD多肽、iDPP纳米粒、载药复合物及其制备方法和应用
CN111743880B (zh) 一种单抗类药物口服纳米-微球制剂及其制备方法
CN103120797B (zh) 还原响应的纳米药物载体、纳米药物颗粒与纳米药物颗粒制剂及其制备方法
CN117462514B (zh) 一种活性氧响应性释药的脂质纳米粒及其制备方法和应用
CN108379241A (zh) 胆甾醇疏水改性普鲁兰-多奈哌齐-聚山梨酯80纳米粒子及制备和应用
CN118767149A (zh) 一种细菌外膜囊泡包裹紫杉醇纳米粒的药物载体及其制法